Loss of SMARCA4 function in MCL results in loss of chromatin accessibility at the ATF3 locus, leading to reduced expression of ATF3, which is a direct repressor of BCL-xL expression65. This evidence concerns the gene SMARCA4 and mantle cell lymphoma.